‘World first’ as mass Covid-19 vaccine trial begins in Bradford. Professor leading study makes urgent plea for more BAME volunteers: The University of Bradford is hosting one of the world’s first mass Covid-19 vaccine trials, beginning today (Tues Oct 6).US biotechnology company Novavax is working with Bradford Institute for Health Research (BIHR), part of the […]
Read More… from University of Bradford Covid-19 vaccine trial
Imperial researchers are set to begin trials to assess the safety and effectiveness of two of the UK’s coronavirus vaccines in development, when inhaled into the lungs. The clinical team will compare COVID-19 vaccine candidates being developed by both Imperial College London and Oxford University, delivering the vaccines directly to the respiratory tract of human […]
New tool outsmarts COVID-19 virus to help vaccine development: Melbourne researchers have developed a tool to monitor mutations that make it difficult to develop coronavirus (COVID-19) vaccines and drugs. Ensuring treatments remain effective as the virus mutates is a huge challenge for researchers. The powerful new tool harnesses genomic and protein information about the virus […]
Read More… from Monitoring mutations to help vaccine development
CSL to manufacture and supply University of Queensland and Oxford University vaccine candidates for Australia Heads of Agreement signed between CSL and the Australian Government to supply 51 million doses of University of Queensland vaccine to Australia, with first doses scheduled for release from mid-2021 following successful clinical trials. Heads of Agreement signed between CSL […]
Read More… from Onshore manufacture for vaccine candidates in Australia
Chronic hepatitis B infections represent a global health problem that could hitherto only be treated by chemotherapy. A team of researchers led by Rudolf Valenta from MedUni Vienna’s Center for Pathophysiology, Infectiology and Immunology has now demonstrated that a protein contained in the BM32 vaccine against grass pollen allergy induces antibodies that prevent the hepatitis […]
Read More… from Chronic hepatitis B: vaccine against grass pollen allergy potential treatment
Oxford Vaccine Raises Hope: When Will First Covid-19 Vaccine Be Available? The world is breathing a sigh of relief after scientists at Oxford University, in a paper published in The Lancet, said their experimental Covid vaccine had been shown to trigger a protective immune response in hundreds of people who got the shot. So, when […]
Read More… from Mass upscale manufacture of Oxford vaccine to go ahead
Researchers at the University of East Anglia (UEA) are investigating uptake of the flu vaccine among care home staff in a bid to see if lessons can be learned to encourage people to have a COVID-19 immunisation. This winter could see flu season coincide with a second wave of COVID-19, so ensuring high flu vaccine […]
Imperial College London’s COVID-19 vaccine trial is expanding to additional sites throughout England. From next week, the ground-breaking vaccine, which has received more donations, will be trialled in six additional centres. Preclinical studies have shown that the vaccine produced highly specific antibodies against SARS-CoV-2 in mice, which were able to neutralise the virus. The vaccine […]
Read More… from Imperial COVID-19 vaccine trial expands to additional sites
There has been a reported breakthrough in the race to develop a Covid-19 vaccine by scientists at Oxford University. An immune response to the new vaccine called ChAdOx1 nCoV-19 has indicated a strong “double defence”, whereby both antibodies and “killer” T-cells were reported to have been present in blood samples from volunteers in the first […]
Read More… from University of Oxford double defence vaccine development
A safe and effective vaccine against COVID-19 is generally regarded as the only way out of the COVID-19 crisis, especially if a widely predicted second wave develops. In this episode, RSM President-Elect Roger Kirby is joined by Professor Robin Shattock, Head of Mucosal Infection and Immunity at Imperial College London and Dr Thomas Breuer, Chief […]